首页> 中文期刊> 《河南职工医学院学报》 >2013-2014年某医院大肠埃希氏菌耐药性分析

2013-2014年某医院大肠埃希氏菌耐药性分析

         

摘要

Objective To understand the current hospital infection of pathogenic bacteria distribution and the antimicrobial resistance , and to provide reference for clinical rational use of antimicrobial drugs . Methods Using VITEK system or API for strain identification , determination of bacterial drug sensitivity by disc diffusion method ( K-B) .Results From 2013 to 2014 , the main pathogenic bacteria in hospital clinical infection of gram-negative bacteria, Escherichia coli ( E.coli) accounted for 25.8%.E.coli were resistant to azlocillin , azithromycin, ceftriaxone and levofloxacin , which showed a resistance fre-quency above 40%.On the other hand , it was relatively sensitive to amikacin , gatifloxacin ,cefoperazone and clindamycin .There was a statistical significance of drug resistance between 2013 and 2014 .Conclu-sion E.coli resistance phenomenon is relatively serious .Medicine choice should be based on the patho-genic bacteria distribution and drug resistance .%目的:了解2013年—2014年某县级医院感染病原菌分布及对抗菌药物的耐药率,为临床合理选用抗菌药物提供参考依据。方法采用VITEK系统或API系统进行菌株鉴定,细菌药物敏感性测定采用纸片扩散法( K-B法)。结果2013年—2014年该院临床感染的主要病原菌为革兰阴性菌,大肠埃希氏菌占25.8%。在耐药药物中,其对阿洛西林、阿奇霉素、头孢曲松、左氧氟沙星的耐药率均在40%以上。对阿米卡星、加替沙星、头孢哌酮和克林霉素较为敏感。其耐药率在两年的变迁有统计学意义(χ2=25.145,P<0.01) 。结论大肠埃希氏菌耐药现象比较严重,应根据病原菌的分布及其耐药性合理选用抗菌药物。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号